Blue Earth Diagnostics and Northern California PET Imaging Center Announce Region’s First Commercial AxuminTM (Fluciclovine F 18) Administration
“We are committed to providing cutting-edge molecular imaging to help improve the quality of patient care,” said Steven Falen, M.D., Ph.D., Medical Director of Northern California PET Imaging Center. “Axumin is a new PET imaging agent to help identify sites of disease in biochemically recurrent prostate cancer patients.
Read the full Press Release or FAQ
